WOBURN, Mass., Jan. 24, 2017 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Company will host a conference call and live webcast on Thursday, January 26th to provide investors with a presentation on the highlights of the 2016 Camelina Field Test results for the C3003 yield trait. Yield10 is focusing on developing disruptive technologies for step-change improvements to crop yield to enhance global food security.
Conference Call Information
Management will host the investor presentation conference call on Thursday, January 26th, 2017 at 4:30 p.m. (ET). A live webcast of the call, including the slide deck, can be accessed on the Company website at http://www.yield10bio.com in the investor relations section. To participate in the call, dial toll-free 877-709-8150 or 201-689-8354 (international).
To listen to a telephonic replay of the conference call, dial toll-free 877-660-6853 or 201-612-7415 (international) and enter pass code 13653574. The replay will be available for 14 days. In addition, the webcast will be archived on the Company’s website in the investor relations section.
About Yield10
Yield10 Bioscience, Inc. is focused on developing disruptive technologies for producing step-change improvements in crop yield to enhance global food security. Yield10 is leveraging an extensive track record of innovation based around optimizing the flow of carbon intermediates in living systems. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and corn. Yield10 is based in Woburn, MA.
For more information about the company, please visit www.yield10bio.com.
(YTEN-G)
Yield10 Inquiries: Lynne H. Brum, (617) 682-4693, [email protected] Investor Relations Contact: Amato and Partners, LLC 90 Park Avenue, 17th Floor New York, NY 10016 [email protected]


TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 



